Optimization of Extended-Release ZL-004 Nanosuspensions for In Vivo Pharmacokinetic Study to Enhance Low Solubility and Compliance

ZL-004, a promising small molecule that increases white blood cell counts, was developed for extended-release nanosuspensions to improve low solubility and compliance of patients. In vivo pharmacokinetic studies of nanosuspensions with different particle sizes and administration volumes were conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Chengyue, Chen, Yanna, Zhu, Junzhe, Wang, Jiaxin, Xu, Ying, Luan, Hansen, Wang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337511/
https://www.ncbi.nlm.nih.gov/pubmed/30577480
http://dx.doi.org/10.3390/molecules24010007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337511/
https://www.ncbi.nlm.nih.gov/pubmed/30577480
http://dx.doi.org/10.3390/molecules24010007

Ejemplares similares